336 / 1068
The Royal Marsden
MERCURY trial
•
2002-2003
•
11 international centres (30 radiologists)
•
295 patients undergoing primary surgery
•
Policy to avoid radiotherapy for mrCRM clear,
mrEMVI negative, T3b or less rectal cancers,
regardless of N stage